Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.

Radiat Oncol · 2012 · PMC3432009 · PMID 22656865

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Pulmonary tests showed a slight trend in favor of Tomotherapy, which will need confirmation with longer follow-up of patients.

also in 4,078 other papers

showed a trendno p-value reported

Regarding the trial's primary endpoint, the results showed a trend of reduced lung toxicities but not significant enough to warrant early stopping of the trial.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.